Latest Insider Transactions at Global Blood Therapeutics, Inc. (GBT)
This section provides a real-time view of insider transactions for Global Blood Therapeutics, Inc. (GBT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Global Blood Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Global Blood Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 05
2022
|
Scott W Morrison Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
6,637
-100.0%
|
-
|
|
Oct 05
2022
|
Mark L Perry Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
37,865
-100.0%
|
-
|
|
Oct 05
2022
|
Deval L Patrick Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
9,037
-100.0%
|
-
|
|
Oct 05
2022
|
Alexis A. Thompson Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,308
-100.0%
|
-
|
|
Oct 05
2022
|
Wendy L Yarno Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
11,437
-100.0%
|
-
|
|
Oct 05
2022
|
Philip A. Pizzo Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
9,112
-100.0%
|
-
|
|
Oct 05
2022
|
Dawn Svoronos Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
5,376
-100.0%
|
-
|
|
Oct 05
2022
|
Glenn Pierce Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
26,437
-100.0%
|
-
|
|
Oct 05
2022
|
Kim Smith Whitley Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
5,980
-100.0%
|
-
|
|
Oct 05
2022
|
David Lee Johnson Chief Commercial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
34,384
-100.0%
|
-
|
|
Oct 05
2022
|
Ted W Love President and CEO |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
346,300
-100.0%
|
-
|
|
Oct 05
2022
|
Ted W Love President and CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
576,318
-100.0%
|
-
|
|
Oct 05
2022
|
Nazila Habibizad Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
39,680
-100.0%
|
-
|
|
Oct 05
2022
|
Carrie Krehlik Chief Human Resources Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
6,716
-100.0%
|
-
|
|
Oct 05
2022
|
Tricia Borga Suvari Chief Legal Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
43,077
-100.0%
|
-
|
|
Oct 05
2022
|
Jeffrey S Farrow Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
26,739
-100.0%
|
-
|
|
Oct 05
2022
|
Jung Choi Officer |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
25,000
-100.0%
|
-
|
|
Oct 05
2022
|
Jung Choi Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
226,672
-100.0%
|
-
|
|
Oct 01
2022
|
Nazila Habibizad Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,557
+1.91%
|
-
|
|
Sep 29
2022
|
Nazila Habibizad Officer |
SELL
Bona fide gift
|
Direct |
3,500
-8.41%
|
-
|
|
Sep 29
2022
|
Jung Choi Officer |
SELL
Bona fide gift
|
Direct |
73,855
-24.58%
|
-
|
|
Sep 28
2022
|
David Lee Johnson Chief Commercial Officer |
SELL
Bona fide gift
|
Direct |
22,000
-39.02%
|
-
|
|
Sep 27
2022
|
Nazila Habibizad Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
29,755
+10.92%
|
$1,160,445
$39.55 P/Share
|
|
Sep 27
2022
|
Ted W Love President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
18,291
+3.08%
|
$292,656
$16.4 P/Share
|
|
Sep 27
2022
|
Jeffrey S Farrow Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,653
+46.94%
|
$378,448
$16.4 P/Share
|
|
Sep 27
2022
|
Jung Choi Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
99,489
+6.05%
|
$1,790,802
$18.48 P/Share
|
|
Sep 13
2022
|
Ted W Love President and CEO |
BUY
Bona fide gift
|
Indirect |
35,300
+12.86%
|
-
|
|
Sep 13
2022
|
Ted W Love President and CEO |
SELL
Bona fide gift
|
Direct |
35,300
-5.95%
|
-
|
|
Sep 09
2022
|
Ted W Love President and CEO |
SELL
Bona fide gift
|
Direct |
221,200
-27.16%
|
-
|
|
Sep 01
2022
|
Nazila Habibizad Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,342
-10.16%
|
$91,256
$68.15 P/Share
|
|
Sep 01
2022
|
Nazila Habibizad Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,878
+13.75%
|
-
|
|
Sep 01
2022
|
David Lee Johnson Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,103
-3.6%
|
$143,004
$68.15 P/Share
|
|
Sep 01
2022
|
David Lee Johnson Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,971
+4.16%
|
-
|
|
Sep 01
2022
|
Kim Smith Whitley Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
607
-9.21%
|
$41,276
$68.15 P/Share
|
|
Sep 01
2022
|
Kim Smith Whitley Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,208
+25.1%
|
-
|
|
Sep 01
2022
|
Carrie Krehlik Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,552
-34.59%
|
$241,536
$68.15 P/Share
|
|
Sep 01
2022
|
Carrie Krehlik Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,268
+33.85%
|
-
|
|
Sep 01
2022
|
Ted W Love President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,200
-1.12%
|
$625,600
$68.15 P/Share
|
|
Sep 01
2022
|
Ted W Love President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
18,553
+1.12%
|
-
|
|
Sep 01
2022
|
Tricia Borga Suvari Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,881
-4.18%
|
$127,908
$68.15 P/Share
|
|
Sep 01
2022
|
Tricia Borga Suvari Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,971
+5.38%
|
-
|
|
Sep 01
2022
|
Jeffrey S Farrow Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
31,441
-91.06%
|
$2,137,988
$68.0 P/Share
|
|
Sep 01
2022
|
Jeffrey S Farrow Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,885
-5.18%
|
$128,180
$68.15 P/Share
|
|
Sep 01
2022
|
Jeffrey S Farrow Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,971
+6.6%
|
-
|
|
Sep 01
2022
|
Jung Choi Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,861
-0.92%
|
$126,548
$68.15 P/Share
|
|
Sep 01
2022
|
Jung Choi Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,971
+1.22%
|
-
|
|
Aug 31
2022
|
Nazila Habibizad Officer |
BUY
Grant, award, or other acquisition
|
Direct |
414
+4.25%
|
$10,350
$25.37 P/Share
|
|
Aug 31
2022
|
David Lee Johnson Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
365
+0.68%
|
$9,125
$25.37 P/Share
|
|
Aug 31
2022
|
Tricia Borga Suvari Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
385
+0.95%
|
$9,625
$25.37 P/Share
|
|
Aug 18
2022
|
Nazila Habibizad Officer |
SELL
Open market or private sale
|
Direct |
4,678
-34.41%
|
$313,426
$67.19 P/Share
|